The reduction of amphotericin B (AmB)-induced renal tubular apoptosis and nephrotoxicity by N-acetylcysteine (NAC) in a murine model was evaluated. Four groups of rats were treated with AmB for 5 days, and each group concomitantly received two doses of 30, 60, or 120 mg of NAC/kg of body weight/day or sterile water for 5 days. Groups that received concomitant NAC at any dose had significantly decreased levels of apoptosis compared to that in animals receiving AmB only (48.8% versus 27.4, 23.6, or 23.5%, respectively; P < 0.001).Nephrotoxicity is the major dose-limiting side effect of amphotericin B (AmB) deoxycholate (14,16,34). AmB-induced nephrotoxicity is usually reversible; however, up to 15% of patients may require dialysis, resulting in extended hospital stays and increased mortality (3,34). Nephrotoxicty is secondary to renal vasoconstriction, which leads to tubular damage and a decreased glomerular filtration rate (GFR) (11,14,15). The mechanism of renal tubular damage has not been fully elucidated; however, AmB has been suggested previously to induce dose-dependent renal tubular cell apoptosis (32).Several approaches to decreasing the incidence of AmB nephrotoxicity have been proposed. These approaches include prehydrating the drug formulation with saline and prolonging the infusion time (10, 18), infusing the drug in a fat emulsion (Intralipid) solution (7,19,21,25,27), and coadministering the drug with mannitol (6); however, none of these approaches have proven to be effective. While lipid formulations of AmB were found to be less nephrotoxic than other formulations of the drug, these formulations do not completely eliminate nephrotoxicity (9,17,23,35).Recently, Varlam et al. demonstrated that AmB causes a dose-dependent apoptotic effect in rat renal tubular cells, with ensuing nephrotoxicity (32). They also showed that AmB-induced apoptosis and the resulting nephrotoxicity can be reduced by the concomitant use of recombinant human insulinlike growth factor 1 (rhIGF-1), an antiapoptotic agent.N-Acetylcysteine (NAC) is an antiapoptotic and antioxidant drug, and NAC administration prior to the administration of radiocontrast agents prevents the nephrotoxicity associated with these agents (4, 5, 30). The purpose of our study was to evaluate the effect of the concomitant administration of NAC on AmB-induced renal tubular cell apoptosis.(An abstract describing this study was presented at the 46th Interscience Conference on Antimicrobial Agents and Chemotherapy, 2006 [22].)Three-week-old male Sprague-Dawley rats weighing 100 g on average were maintained in individual cages. The animals had free access to a standard diet and received water ad libitum. Prior to the experiments, rats were randomized and divided into four groups consisting of 10 animals each. Animals in each of the groups (A, B, C, and D) were treated with 10 mg of intraperitoneal (i.p.) AmB deoxycholate (Bristol-Myers Squibb)/kg of body weight/day for 5 days. In addition to AmB, group A was given i.p. sterile water and groups B, C, and D were ...